Analyst Price Target is $25.60
▲ +17.70% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Myovant Sciences in the last 3 months. The average price target is $25.60, with a high forecast of $32.00 and a low forecast of $18.00. The average price target represents a 17.70% upside from the last price of $21.75.
Current Consensus is
The current consensus among 6 polled investment analysts is to buy stock in Myovant Sciences. This rating changed within the last month from a Hold consensus rating.